NEW YORK and HAIKOU CITY, China, Nov. 5 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, today announced it will release its third Quarter 2008 results on Friday, November 7, 2008. In conjunction, the Company will host an earning conference call at 10:00 a.m. EST on Friday, November 7, 2008 to discuss these results.
Ms. Zhilin Li, President and CEO of China Pharma Holdings, Inc., Mr. Xinhua Wu, Chief Financial Officer, and Ms. Sara Ephraim, Vice President of the company's IR firm, The Ruth Group, will be hosting the call. To participate in the conference call, please dial 1-800-591-6945 ten minutes prior to the scheduled conference call time. International callers should dial 1-617-614-4911. The conference pass code is 57906502.
If you are unable to participate in the call at this time, a replay will be available on Friday, November 7 at 12:00 p.m. EST, through Friday, November 14. To access the replay, please dial 1-888-286-8010. International callers should dial 1-617-801-6888. The conference pass code is 19590263. This conference call will be broadcast live over the Internet and can be accessed by clicking this link: http://phx.corporate-ir.net/playerlink.zhtml?c=145098&s=wm&e=2018680 . A replay will also be available shortly after the call on China Pharma' website http://www.chinapharmaholdings.com .
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a biopharmaceutical company with rapidly
growing profit that develops, manufactures, and markets treatments for a
wide range of high incidence and high mortality conditions in China,
including cardiovascular, CNS, infectious, and digestive diseases. The
|SOURCE China Pharma Holdings, Inc.|
Copyright©2008 PR Newswire.
All rights reserved